These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 11238953

  • 1. Activation of Akt (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression.
    Hutchinson J, Jin J, Cardiff RD, Woodgett JR, Muller WJ.
    Mol Cell Biol; 2001 Mar; 21(6):2203-12. PubMed ID: 11238953
    [Abstract] [Full Text] [Related]

  • 2. Requirement for both Shc and phosphatidylinositol 3' kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis.
    Webster MA, Hutchinson JN, Rauh MJ, Muthuswamy SK, Anton M, Tortorice CG, Cardiff RD, Graham FL, Hassell JA, Muller WJ.
    Mol Cell Biol; 1998 Apr; 18(4):2344-59. PubMed ID: 9528804
    [Abstract] [Full Text] [Related]

  • 3. FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity.
    Dijkers PF, Birkenkamp KU, Lam EW, Thomas NS, Lammers JW, Koenderman L, Coffer PJ.
    J Cell Biol; 2002 Feb 04; 156(3):531-42. PubMed ID: 11815629
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits wnt-1-induced mammary tumorigenesis.
    Zhao H, Cui Y, Dupont J, Sun H, Hennighausen L, Yakar S.
    Cancer Res; 2005 Aug 01; 65(15):6864-73. PubMed ID: 16061670
    [Abstract] [Full Text] [Related]

  • 5. Prolactin and transforming growth factor-beta signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway.
    Bailey JP, Nieport KM, Herbst MP, Srivastava S, Serra RA, Horseman ND.
    Mol Endocrinol; 2004 May 01; 18(5):1171-84. PubMed ID: 14963111
    [Abstract] [Full Text] [Related]

  • 6. Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.
    Hutchinson JN, Jin J, Cardiff RD, Woodgett JR, Muller WJ.
    Cancer Res; 2004 May 01; 64(9):3171-8. PubMed ID: 15126356
    [Abstract] [Full Text] [Related]

  • 7. Estrogen regulation of Pak1 and FKHR pathways in breast cancer cells.
    Mazumdar A, Kumar R.
    FEBS Lett; 2003 Jan 30; 535(1-3):6-10. PubMed ID: 12560069
    [Abstract] [Full Text] [Related]

  • 8. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
    Amundadottir LT, Leder P.
    Oncogene; 1998 Feb 12; 16(6):737-46. PubMed ID: 9488037
    [Abstract] [Full Text] [Related]

  • 9. Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution.
    Shin DH, Jang SH, Kang BC, Kim HJ, Oh SH, Kong G.
    J Cell Physiol; 2011 May 12; 226(5):1340-52. PubMed ID: 20945346
    [Abstract] [Full Text] [Related]

  • 10. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).
    Brunet A, Park J, Tran H, Hu LS, Hemmings BA, Greenberg ME.
    Mol Cell Biol; 2001 Feb 12; 21(3):952-65. PubMed ID: 11154281
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.
    Sun Y, Strizzi L, Raafat A, Hirota M, Bianco C, Feigenbaum L, Kenney N, Wechselberger C, Callahan R, Salomon DS.
    Am J Pathol; 2005 Aug 12; 167(2):585-97. PubMed ID: 16049342
    [Abstract] [Full Text] [Related]

  • 12. Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity.
    Qiao H, Saulnier R, Patryzkat A, Rahimi N, Raptis L, Rossiter J, Tremblay E, Elliott B.
    Cell Growth Differ; 2000 Feb 12; 11(2):123-33. PubMed ID: 10714768
    [Abstract] [Full Text] [Related]

  • 13. Activation of phosphatidylinositol 3-kinase by membrane localization of p110alpha predisposes mammary glands to neoplastic transformation.
    Renner O, Blanco-Aparicio C, Grassow M, Cañamero M, Leal JF, Carnero A.
    Cancer Res; 2008 Dec 01; 68(23):9643-53. PubMed ID: 19047141
    [Abstract] [Full Text] [Related]

  • 14. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice.
    White DE, Cardiff RD, Dedhar S, Muller WJ.
    Oncogene; 2001 Oct 25; 20(48):7064-72. PubMed ID: 11704830
    [Abstract] [Full Text] [Related]

  • 15. Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model.
    Shukla S, Maclennan GT, Marengo SR, Resnick MI, Gupta S.
    Prostate; 2005 Aug 01; 64(3):224-39. PubMed ID: 15712212
    [Abstract] [Full Text] [Related]

  • 16. Transforming acidic coiled coil 1 promotes transformation and mammary tumorigenesis.
    Cully M, Shiu J, Piekorz RP, Muller WJ, Done SJ, Mak TW.
    Cancer Res; 2005 Nov 15; 65(22):10363-70. PubMed ID: 16288026
    [Abstract] [Full Text] [Related]

  • 17. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
    Forrester E, Chytil A, Bierie B, Aakre M, Gorska AE, Sharif-Afshar AR, Muller WJ, Moses HL.
    Cancer Res; 2005 Mar 15; 65(6):2296-302. PubMed ID: 15781643
    [Abstract] [Full Text] [Related]

  • 18. Mammary gland involution is delayed by activated Akt in transgenic mice.
    Schwertfeger KL, Richert MM, Anderson SM.
    Mol Endocrinol; 2001 Jun 15; 15(6):867-81. PubMed ID: 11376107
    [Abstract] [Full Text] [Related]

  • 19. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.
    Cancer Res; 2006 May 01; 66(9):4672-80. PubMed ID: 16651418
    [Abstract] [Full Text] [Related]

  • 20. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression.
    Cappellini A, Tabellini G, Zweyer M, Bortul R, Tazzari PL, Billi AM, Falà F, Cocco L, Martelli AM.
    Leukemia; 2003 Nov 01; 17(11):2157-67. PubMed ID: 12931221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.